AbbVie Reports Third-Quarter 2026 Financial Results
Revenue$17.404 billion+10.3% YoY
EPS$2.37
Outlookraisedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.